Lenvatinib is More Effective & Safer Than Sorafenib in the Treatment of Renal Cell Carcinoma - A Single-Center Retrospective Analysis of 70 Cases. JOC. 2024;23(1):624-628. doi:10.64149/J.Carcinog.23.1.624-628